BMS-986466
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986466, covering 2025-07-22 to 2025-07-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors [Phase 1, Phase 2]